Kazuyuki Shimada

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Medicine, Cardiology, Pharmacology +12

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara et al. · The Lancet · 2002 · 1.7K citations

Medicine, Rehabilitation Medicine, Surgery +16

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 319 citations

Medicine, Cardiology, Preventive Medicine +16

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch et al. · Blood · 2011 · 292 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells

Keisuke Watanabe, Seitaro Terakura, Anton C. Martens et al. · The Journal of Immunology · 2014 · 285 citations · Full text

Life Sciences, Cell Biology, Immunology +17